The impact of COVID-19 pandemic on urological emergencies: a single-center experience.


Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 16 04 2020
accepted: 14 05 2020
pubmed: 25 5 2020
medline: 30 6 2021
entrez: 25 5 2020
Statut: ppublish

Résumé

COVID-19 pandemic represents a novel challenge for healthcare systems, and it affects even the daily urological practice. Italy was the first country after China to experience a lock-down period. Our objective is to determine whether, during the COVID-19 period, there has been any modification in urological emergencies. we retrospectively reviewed urgent urological consultations requested by the Emergency Department (ED) of Padua University Hospital in the 36-day period between February 22nd and March 30th, 2020 and compared them to the prior year cases within a similar time frame (February 24th to March 31st, 2019). Pediatric population (age < 15 years); surgical complications and traumas were excluded to avoid confounding from the reduction of activities during the lockdown. The number of daily consultations, the number of invasive procedures performed and admissions were evaluated, together with the predictors of admission were identified through multivariate logistic regression models. The final sample resulted in 107 consultations performed in 2020 and 266 in 2019. A higher number of daily consultations was performed during 2019 (7.33 vs 2.97, p < 0.001). Similarly, the number of daily-invasive procedures was higher in 2019 (p = 0.006), while there was no difference in the number of daily admissions (15 vs 12, p = 0.80). On multivariate analysis, the year (2020 vs 2019, OR 2.714, 95% CI 1.096-6.757, p = 0.0297) was a significant predictor of admission. Urgent urology practice was affected during COVID-19 pandemic with a remarkable reduction in urgent urological consultations; furthermore, a higher risk of admissions was observed in 2020. The consequences of a potentially delayed diagnosis remain to be determined.

Identifiants

pubmed: 32447443
doi: 10.1007/s00345-020-03264-2
pii: 10.1007/s00345-020-03264-2
pmc: PMC7245166
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1985-1989

Références

Eur Urol. 2020 Jun;77(6):663-666
pubmed: 32279903
Nat Rev Urol. 2020 May;17(5):251-253
pubmed: 32203310
Eur Urol. 2020 Aug;78(2):131-133
pubmed: 32303384
Minerva Urol Nefrol. 2020 Jun;72(3):376-383
pubmed: 32225135
Minerva Urol Nefrol. 2020 Jun;72(3):369-375
pubmed: 32202401
Eur Urol. 2020 Jul;78(1):21-28
pubmed: 32376137
Lancet. 2020 Apr 11;395(10231):1225-1228
pubmed: 32178769
Lancet. 2020 Feb 15;395(10223):470-473
pubmed: 31986257

Auteurs

Giovanni Motterle (G)

Clinica Urologica, Department of Surgical and Oncological Sciences, University of Padova, Via Giustiniani, 2, 35100, Padova, Italy.

Alessandro Morlacco (A)

Clinica Urologica, Department of Surgical and Oncological Sciences, University of Padova, Via Giustiniani, 2, 35100, Padova, Italy.

Massimo Iafrate (M)

Clinica Urologica, Department of Surgical and Oncological Sciences, University of Padova, Via Giustiniani, 2, 35100, Padova, Italy.

Marta Bianco (M)

Clinica Urologica, Department of Surgical and Oncological Sciences, University of Padova, Via Giustiniani, 2, 35100, Padova, Italy.

Giuliano Federa (G)

Clinica Urologica, Department of Surgical and Oncological Sciences, University of Padova, Via Giustiniani, 2, 35100, Padova, Italy.

Orest Xhafka (O)

Clinica Urologica, Department of Surgical and Oncological Sciences, University of Padova, Via Giustiniani, 2, 35100, Padova, Italy.

Filiberto Zattoni (F)

Clinica Urologica, Department of Surgical and Oncological Sciences, University of Padova, Via Giustiniani, 2, 35100, Padova, Italy.

Tommaso Prayer-Galetti (T)

Clinica Urologica, Department of Surgical and Oncological Sciences, University of Padova, Via Giustiniani, 2, 35100, Padova, Italy. tommaso.prayer@aopd.veneto.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH